Germany sets up new agency to oversee production of medicinal cannabisBMJ 2017; 356 doi: https://doi.org/10.1136/bmj.j706 (Published 08 February 2017) Cite this as: BMJ 2017;356:j706
- Ned Stafford
Germany’s Federal Institute for Drugs and Medical Devices, known by the acronym BfArM, is creating an agency to oversee the cultivation of marijuana and the subsequent production of cannabis to be used medicinally, in line with a new law approved by the Bundestag, Germany’s lower house of parliament.
The new law legalises cannabis based medicines to treat pain, nausea from chemotherapy, and other chronic ailments. It mandates that Germany’s massive public health insurance system cover the cost of cannabis medicines prescribed by doctors. Under the previous law cannabis could be used for medical …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial